Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Relay Therapeutics
Biotech
Relay breast cancer data tee up clash with AstraZeneca's Truqap
Relay beat its survival goal in the study, positioning the biotech to start a pivotal trial that could establish it as a challenger to AstraZeneca.
Nick Paul Taylor
Sep 9, 2024 7:00am
Relay loses interest in SHP2 inhibitor after Genentech leaves
Aug 7, 2024 6:00am
Genentech sinks SHP2 pact, leaving Relay to race thinning field
Jul 17, 2024 8:01am
OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot
May 13, 2024 10:36am
IRA drives Relay to pause plans to win approval in rare cancer
Oct 13, 2023 6:45am
Gilead taps Roche exec to fly Kite—Chutes & Ladders
May 19, 2023 9:30am